Over three million Australians suffer from arthritis and musculoskeletal conditions.

Arthritis and musculoskeletal conditions are serious and debilitating diseases.  

Osteoarthritis, rheumatoid arthritis and osteoporosis are the most prevalent forms of musculoskeletal disease within Australia and have been found to place the highest burden on the community. Their inclusion as a National Health Priority Area represents the Australian Government's commitment to ensuring a better quality of life for suffers and their families.

(Source: NHPA website).

Information on the impact of Cochrane reviews on arthritis and musculoskeletal health care will be available on this site.  Evidence-Based Policy Network members will be notified of its availability in the EBPN bulletin. 

• Subscribe to the EBPN bulletin

Model for use of Cochrane reviews in health policy

An example from asthma has been provided to demonstrate the potential of embedding Cochrane reviews in policy making processes.  This may provide a model that could be implemented in other areas of healthcare:

• Impact of Cochrane reviews on asthma: a possible model for informing health policy

If you would like to share an example of how you have used Cochrane reviews to inform your work please email the details to Marie Misso.

This website is produced and maintained  by the Australasian Cochrane Centre for members of the Evidence-Based Policy Network, Australian Government Department of Health and Ageing.